Ajanta Pharma Limited, 98, Ajanta House, Charkop, Kandivili (West), Mumbai, 400 067, India

Company Name : Ajanta Pharma Limited

Address : 98, Ajanta House, Charkop, Kandivili (West), Mumbai, 400 067, India

Tel No: 91 22 6606 1000

Email : info@ajantapharma.com, busdev@ajantapharma.com

Website : http://www.ajantapharma.com/

Company Profile: Ajanta Pharma is a specialty pharmaceutical company engaged in development, manufacture and marketing of quality finished dosages in domestic and international markets. Established in 1973 and headquartered in Mumbai-India, we are committed to ‘Serve Health Care Needs Worldwide’. Ajanta has been consistently providing high quality affordable medicines to patients in different parts of the world.

We employ over 4,000 people worldwide and our products are sold in over 40 countries. Ajanta operates with 5 state-of-the art manufacturing facilities that produce high quality pharmaceutical products. We focus on commercializing unique generic products and pioneering synergistic combination products in the therapeutic areas of anti-malarial, Cardiovascular, dermatology, male erectile dysfunction, musculoskeletal, and ophthalmology.

In India, we have significant presence in the fast growing speciality therapeutic segments of Cardiovascular, dermatology, ophthalmology and musculoskeletal. With primary focus on new product innovation and introduction, we have been consistently identifying unmet medical needs and introducing many first-to-market products to cater to those needs. Our products provide patient compliance and convenience over existing therapeutic options. Gaining first mover advantage, many of our brands hold leadership positions in their respective sub- therapeutic segments.

Ajanta has extensive presence in many countries in Asia, Africa and Latin America with customized product portfolio to suit the needs of each country. Having successfully gone through USFDA inspection, we have started commercial operations in the US market in the first quarter of 2013. With a portfolio of 25 ANDAs which have been filed with the US FDA, we look forward to the US market to be our key growth driver in coming years.

We have an advanced Research & Development Centre for finished formulations and Active Pharmaceutical Ingredient (API) synthesis of different dosage forms. ‘Advent’, our R&D centre has a team of over 300 scientists working on innovative products for various markets across the globe. We have acquired strong capabilities for developing generic formulations and process chemistry over the years.

Committed to patient care since inception, our focus on speciality segments in India and simultaneous opening of new international markets has been accelerating our growth over the years. Ajanta’s team members are driven to fulfill its mission; a commitment to ‘Serving Global Healthcare needs with Empathy, Innovation & Technology’.

The company is listed on both the prominent stock exchanges in India viz. BSE & NSE (BSE: 532331 | NSE: AJANTPHARM).